Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/ONT stock hub

LON/ONT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/ONTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/ONT

In the news

Latest news · LON/ONT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-27.7

P25 -54.2P50 2.1P75 13.7

ROIC-14.4

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/ONT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

178

Groups with data

Currency

GBP

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	1,316
Employees Change	-66%
Employees Change Percent	-4.78
Enterprise value	GBX 880.3M
Exchange	London Stock Exchange
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BP6S8Z30
Last refreshed	2026-05-10
Market cap	GBX 1.1B
Price	GBX 113
Price currency	GBX
Rev Per Employee	170,136.78x
Sector	Healthcare
Sic	2836
Symbol	lon/ONT
Website	https://nanoporetech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.27%
EV Earnings	-6.06x
EV/FCF	-11.88x
EV/Sales	3.93x
FCF yield	-6.77%
P/B ratio	2.36x
P/S ratio	4.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-58.6%
EBITDA Margin	-51.63%
Gross margin	60.92%
Gross Profit	GBX 136.4M
Gross Profit Growth	16.29%
Gross Profit Growth Q	34.17%
Gross Profit Growth3 Y	14.68%
Gross Profit Growth5 Y	7.41%
Net Income	GBX -145.2M
Net Income Growth Years	2%
Pretax Margin	-62.48%
Profit Margin	-64.85%
Profit Per Employee	GBX -110,334
ROA	-12.02
Roa5y	-12.68
ROCE	-26.01
ROE	-27.67
Roe5y	-25.05
ROIC	-14.42

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-5.28%
Cagr3y	-21.13%
EPS Growth Years	2
Revenue Growth	22.22x
Revenue Growth Q	19.37x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	10.1x
Revenue Growth5 Y	6.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.33
Assets	GBX 622.5M
Cash	GBX 255.3M
Current Assets	GBX 420M
Current Liabilities	GBX 118M
Debt	GBX 41.5M
Debt Equity	GBX 0.09
Debt FCF	GBX -0.56
Equity	GBX 463.3M
Interest Coverage	-46.86
Liabilities	GBX 159.2M
Long Term Assets	GBX 202.5M
Long Term Liabilities	GBX 41.2M
Net Cash	GBX 213.8M
Net Cash By Market Cap	GBX 19.54
Net Cash Growth	-26.86%
Net Debt Equity	GBX -0.46
Tangible Book Value	GBX 407.5M
Tangible Book Value Per Share	GBX 0.42
WACC	8.89

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.56
Inventory Turnover	0.97
Net Working Capital	GBX 51.9M
Quick ratio	2.73
Working Capital	GBX 302M
Working Capital Turnover	GBX 0.63

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.04%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-5.28%
200-day SMA	145.5
3Y total return	-50.95%
50-day SMA	117.6
50-day SMA vs 200-day SMA	50under200
All Time High	736
All Time High Change	-84.63%
All Time High Date	2021-12-02
All Time Low	85
All Time Low Change	33.06%
All Time Low Date	2024-06-27
ATR	6.23
Beta	0.87
Beta1y	1.55
Beta2y	0.85
Ch YTD	-11.92
High	117.8
High52	224.8
High52 Date	2025-08-13
High52ch	-49.69%
Low	111.5
Low52	104
Low52 Date	2026-04-09
Low52ch	8.75%
Ma50ch	-3.84%
Price vs 200-day SMA	-22.28%
RSI	46.78
RSI Monthly	41.26
RSI Weekly	41.42
Sharpe ratio	-0.03x
Sortino ratio	0.07
Total Return	-7.04%
Tr YTD	-11.92
Tr1m	-1.82%
Tr1w	-4.07%
Tr3m	-19.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -131.2M
Operating margin	-58.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	395,509,486%
Net Borrowing	-5,800,000
Shares Insiders	0.09%
Shares Institutions	37.07%
Shares Out	967,364,420
Shares Qo Q	0.63%
Shares Yo Y	7.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -94.5M
Average Volume	1,459,643.35x
Bv Per Share	0.48
CAPEX	GBX -3.5M
Ch1m	-1.82
Ch1w	-4.07
Ch1y	-5.28
Ch3m	-19.79
Ch3y	-50.95
Ch6m	-19.21
Change	-1.99%
Change From Open	-1.39
Close	115.4
Days Gap	-0.61
Depreciation Amortization	15,600,000
Dollar Volume	148,329,519
Earnings Date	2026-08-19
EBIT	GBX -131.2M
EBITDA	GBX -115.6M
EPS	GBX -0.15
F Score	3
FCF	GBX -74.1M
FCF EV Yield	-8.42x
FCF Per Share	GBX -0.08
Financing CF	-2,100,000
Fiscal Year End	December
Founded	2,005
Income Tax	GBX 5.3M
Investing CF	56,300,000
Is Primary Listing	1
Last Earnings Date	2026-03-02
Last Report Date	2025-12-31
Ma150	132.4
Ma150ch	-14.6%
Ma20	115.4
Ma20ch	-2.01%
Net CF	-18,400,000
Next Earnings Date	2026-08-19
Open	114.7
Position In Range	25.4
Ppne	92,800,000
Price Date	2026-05-08
Ptbv Ratio	2.68
Relative Volume	0.92x
Revenue	223,900,000x
SBC By Revenue	9.11x
Share Based Comp	20,400,000
Tax By Revenue	2.37x
Tr6m	-19.21%
Volume	1,311,490
Z Score	4.08

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/ONT pay a dividend?

Capital-return profile for this ticker.

Performance

LON/ONT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/ONT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+37.1%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+7.0%

Negative means the company is buying back shares.

Technical

LON/ONT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.8

Neutral momentum band

Price vs 200-day MA

-22.3%

50/200-day relationship not available

Beta (5Y)

0.87

Moves roughly with the market

Sharpe ratio

-0.03

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/ONT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/ONT stock rating?

lon/ONT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/ONT analysis?

The full report lives at /stocks/lon/ONT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/ONT?

The latest report frames lon/ONT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/ONT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.